English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Allergan, Inc.
Ruth de Jauregui
| Apr 22, 2017
Novartis teaming with Allergan in Phase IIb trial of non-alcoholic steatohepatitis treatment therapy
Tabitha Fleming
| Jan 24, 2017
Allergan continues support for headache research
Jamie Barrand
| Mar 20, 2016
New treatment available for bipolar disorder, schizophrenia
Jamie Barrand
| Mar 17, 2016
Allergan's dry eye disease therapy receives prior approval supplement from FDA
Jamie Barrand
| Dec 17, 2015
Allergan releases new therapy for irritable bowel syndrome
Jamie Barrand
| Dec 7, 2015
Allergan partners with Rugen Therapeutics to develop autism, OCD therapies
Jamie Barrand
| Oct 16, 2015
Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215
Jamie Barrand
| Oct 14, 2015
Allergan releasing generic version of Invega in U.S.
Trending
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 17, 2025
UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+
Pharmaceuticals
Patient Daily
| Apr 22, 2025
National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+
Pharmaceuticals
Patient Daily
| Apr 23, 2025
Empower Pharmacy CEO on pharmaceutical industry pricing disparities: 'Is it fair to charge one person in another country 10 times more?'
